.

Make Better Decisions

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
Express Scripts
Chinese Patent Office
Cerilliant
McKinsey
Citi
Queensland Health
Accenture
Baxter

Generated: November 24, 2017

DrugPatentWatch Database Preview

CEFUROXIME AXETIL Drug Profile

« Back to Dashboard

Which patents cover Cefuroxime Axetil, and when can generic versions of Cefuroxime Axetil launch?

Cefuroxime Axetil is a drug marketed by Aurobindo Pharma Ltd, Sun Pharm Inds Ltd, Sandoz, Lupin, Ranbaxy Labs Ltd, Orchid Hlthcare, Wockhardt, Apotex, Ani Pharms Inc, and Alkem Labs Ltd. and is included in eleven NDAs.

The generic ingredient in CEFUROXIME AXETIL is cefuroxime axetil. There are sixty-one drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the cefuroxime axetil profile page.

Pharmacology for CEFUROXIME AXETIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd
CEFUROXIME AXETIL
cefuroxime axetil
TABLET;ORAL065308-001Mar 29, 2006ABRXNoNo► Subscribe► Subscribe► Subscribe
Orchid Hlthcare
CEFUROXIME AXETIL
cefuroxime axetil
TABLET;ORAL065359-003Feb 15, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Ani Pharms Inc
CEFUROXIME AXETIL
cefuroxime axetil
TABLET;ORAL065190-001Oct 18, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Ltd
CEFUROXIME AXETIL
cefuroxime axetil
FOR SUSPENSION;ORAL065323-001Feb 5, 2008DISCNNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Ltd
CEFUROXIME AXETIL
cefuroxime axetil
TABLET;ORAL065118-001Apr 25, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe
Lupin
CEFUROXIME AXETIL
cefuroxime axetil
TABLET;ORAL065135-002Jul 25, 2003ABRXNoNo► Subscribe► Subscribe► Subscribe
Wockhardt
CEFUROXIME AXETIL
cefuroxime axetil
TABLET;ORAL065166-002Jul 29, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Ltd
CEFUROXIME AXETIL
cefuroxime axetil
FOR SUSPENSION;ORAL065323-002Feb 5, 2008DISCNNoNo► Subscribe► Subscribe► Subscribe
Wockhardt
CEFUROXIME AXETIL
cefuroxime axetil
TABLET;ORAL065166-001Jul 29, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Alkem Labs Ltd
CEFUROXIME AXETIL
cefuroxime axetil
TABLET;ORAL065496-002Jun 7, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
AstraZeneca
McKinsey
Cipla
Citi
Novartis
Farmers Insurance
UBS
Mallinckrodt
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot